144 related articles for article (PubMed ID: 33496065)
41. Development of functional docetaxel nanomicelles for treatment of brain glioma.
Ju RJ; Mu LM; Li XT; Li CQ; Cheng ZJ; Lu WL
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1180-1190. PubMed ID: 29519164
[TBL] [Abstract][Full Text] [Related]
42. Dequalinium induces human leukemia cell death by affecting the redox balance.
García-Pérez AI; Galeano E; Nieto E; Sancho P
Leuk Res; 2011 Oct; 35(10):1395-401. PubMed ID: 21477862
[TBL] [Abstract][Full Text] [Related]
43. Adenoviral natural born killer gene therapy for malignant glioma.
Naumann U; Schmidt F; Wick W; Frank B; Weit S; Gillissen B; Daniel P; Weller M
Hum Gene Ther; 2003 Sep; 14(13):1235-46. PubMed ID: 12952595
[TBL] [Abstract][Full Text] [Related]
44. LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathway.
Yang C; He L; Chen G; Ning Z; Xia Z
Hum Cell; 2019 Jan; 32(1):41-50. PubMed ID: 30426452
[TBL] [Abstract][Full Text] [Related]
45. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
46. Interaction of dequalinium chloride with phosphatidylcholine bilayers: A biophysical study with consequences on the development of lipid-based mitochondrial nanomedicines.
Sauvage F; Legrand FX; Roux M; Rajkovic I; Weiss TM; Varga Z; Augis L; Nugue G; Debouzy JC; Vergnaud-Gauduchon J; Barratt G
J Colloid Interface Sci; 2019 Mar; 537():704-715. PubMed ID: 30497059
[TBL] [Abstract][Full Text] [Related]
47. Effect of dequalinium on K1735-M2 melanoma cell growth, directional migration and invasion in vitro.
Helige C; Smolle J; Zellnig G; Fink-Puches R; Kerl H; Tritthart HA
Eur J Cancer; 1992; 29A(1):124-8. PubMed ID: 1445729
[TBL] [Abstract][Full Text] [Related]
48. Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes.
Weissig V; Lizano C; Torchilin VP
Drug Deliv; 2000; 7(1):1-5. PubMed ID: 10895413
[TBL] [Abstract][Full Text] [Related]
49. Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP).
Dasari VR; Velpula KK; Kaur K; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
PLoS One; 2010 Jul; 5(7):e11813. PubMed ID: 20676365
[TBL] [Abstract][Full Text] [Related]
50. Dequalinium induces cytotoxicity in human leukemia NB4 cells by downregulation of Raf/MEK/ERK and PI3K/Akt signaling pathways and potentiation of specific inhibitors of these pathways.
García-Pérez AI; Galeano E; Nieto E; Estañ MC; Sancho P
Leuk Res; 2014 Jul; 38(7):795-803. PubMed ID: 24811390
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium.
Rotenberg SA; Smiley S; Ueffing M; Krauss RS; Chen LB; Weinstein IB
Cancer Res; 1990 Feb; 50(3):677-85. PubMed ID: 2297708
[TBL] [Abstract][Full Text] [Related]
52. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
Khan M; Yi F; Rasul A; Li T; Wang N; Gao H; Gao R; Ma T
IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
[TBL] [Abstract][Full Text] [Related]
53. Failure to enhance the in vivo killing of human ovarian carcinoma by sequential treatment with dequalinium chloride and tumor necrosis factor.
Manetta A; Emma D; Gamboa G; Liao S; Berman M; DiSaia P
Gynecol Oncol; 1993 Jul; 50(1):38-44. PubMed ID: 8349163
[TBL] [Abstract][Full Text] [Related]
54. DQAsomes as the Prototype of Mitochondria-Targeted Pharmaceutical Nanocarriers : An Update.
Weissig V; Lozoya M; Yu N; D'Souza GGM
Methods Mol Biol; 2021; 2275():13-25. PubMed ID: 34118029
[TBL] [Abstract][Full Text] [Related]
55. EGFR-Targeted Pentacyclic Triterpene Analogues for Glioma Therapy.
Ciftci HI; Radwan MO; Sever B; Hamdy AK; Emirdağ S; Ulusoy NG; Sozer E; Can M; Yayli N; Araki N; Tateishi H; Otsuka M; Fujita M; Altintop MD
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681605
[TBL] [Abstract][Full Text] [Related]
56. Plasmodium berghei: in vitro and in vivo activity of dequalinium.
Rodrigues JR; Gamboa de Domínguez N
Exp Parasitol; 2007 Jan; 115(1):19-24. PubMed ID: 16814285
[TBL] [Abstract][Full Text] [Related]
57. Site of action of suramin and reactive blue 2 in preventing neuronal death induced by dequalinium.
Chan CF; Lin-Shiau SY
J Neurosci Res; 2000 Dec; 62(5):692-9. PubMed ID: 11104507
[TBL] [Abstract][Full Text] [Related]
58. Combination of sonodynamic with temozolomide inhibits C6 glioma migration and promotes mitochondrial pathway apoptosis via suppressing NHE-1 expression.
Chen L; Cong D; Li Y; Wang D; Li Q; Hu S
Ultrason Sonochem; 2017 Nov; 39():654-661. PubMed ID: 28732990
[TBL] [Abstract][Full Text] [Related]
59. Polyphyllin I induces G2/M phase arrest and apoptosis in U251 human glioma cells via mitochondrial dysfunction and the JNK signaling pathway.
Liu J; Zhang Y; Chen L; Yu F; Li X; Dan Tao ; Zhao J; Zhou S
Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):479-486. PubMed ID: 28449039
[TBL] [Abstract][Full Text] [Related]
60. DQAsomes: a novel potential drug and gene delivery system made from Dequalinium.
Weissig V; Lasch J; Erdos G; Meyer HW; Rowe TC; Hughes J
Pharm Res; 1998 Feb; 15(2):334-7. PubMed ID: 9523323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
